Expression of Vascular Endothelial Growth Factor in Adenocarcinomas of the Uterine Cervix and Its Relation to Angiogenesis and p53 and c-erbB-2 Protein Expression-Reference-Cited by-同舟云学术

Expression of Vascular Endothelial Growth Factor in Adenocarcinomas of the Uterine Cervix and Its Relation to Angiogenesis and p53 and c-erbB-2 Protein Expression

Published:2002-06 Issue:3 Volume:85 Page:469-475
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Lee Ji Shin,Kim Hyung Seok,Jung Jong Jae,Lee Min Cheol,Park Chang Soo

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference36 articles.

1. What is the evidence that tumors are angiogenesis dependent?;Folkman;J Natl Cancer Inst,1990

2. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation;Liotta;Cell,1991

3. Angiogenesis in the uterine cervix;Abulafia;Int J Gynecol Cancer,2000

4. Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations;Dellas;Gynecol Oncol,2000

5. Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer;Tjalma;Br J Cancer,1998

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential Influence of Residual or Recurrent Disease on Bevacizumab Treatment Efficacy in Ovarian Cancer: Current Evidence and Future Perspectives;Cancers;2024-03-05

2. Harnessing the Potential of Plant Expression System towards the Production of Vaccines for the Prevention of Human Papillomavirus and Cervical Cancer;Vaccines;2022-12-01

3. Prevalence of HER2 overexpression and amplification in cervical cancer: A systematic review and meta-analysis;PLOS ONE;2021-09-30

4. Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option?;Expert Opinion on Drug Safety;2021-02-15

5. The role of bevacizumab on tumour angiogenesis and in the management of gynaecological cancers: A review;Biomedicine & Pharmacotherapy;2018-06